Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

Archive ouverte

Battelino, Tadej | Danne, Thomas | Bergenstal, Richard | Amiel, Stephanie | Beck, Roy | Biester, Torben | Bosi, Emanuele | Buckingham, Bruce | Cefalu, William | Close, Kelly | Cobelli, Claudio | Dassau, Eyal | Devries, J. Hans | Donaghue, Kim | Dovc, Klemen | Doyle, Francis | Garg, Satish | Grunberger, George | Heller, Simon | Heinemann, Lutz | Hirsch, Irl | Hovorka, Roman | Jia, Weiping | Kordonouri, Olga | Kovatchev, Boris | Kowalski, Aaron | Laffel, Lori | Levine, Brian | Mayorov, Alexander | Mathieu, Chantal | Murphy, Helen | Nimri, Revital | Nørgaard, Kirsten | Parkin, Christopher | Renard, Eric | Rodbard, David | Saboo, Banshi | Schatz, Desmond | Stoner, Keaton | Urakami, Tatsuiko | Weinzimer, Stuart | Phillip, Moshe

Edité par CCSD ; American Diabetes Association -

International audience. Improvements in sensor accuracy, greater convenience and ease of use, and expanding reimbursement have led to growing adoption of continuous glucose monitoring (CGM). However, successful utilization of CGM technology in routine clinical practice remains relatively low. This may be due in part to the lack of clear and agreed-upon glycemic targets that both diabetes teams and people with diabetes can work toward. Although unified recommendations for use of key CGM metrics have been established in three separate peer-reviewed articles, formal adoption by diabetes professional organizations and guidance in the practical application of these metrics in clinical practice have been lacking. In February 2019, the Advanced Technologies & Treatments for Diabetes (ATTD) Congress convened an international panel of physicians, researchers, and individuals with diabetes who are expert in CGM technologies to address this issue. This article summarizes the ATTD consensus recommendations for relevant aspects of CGM data utilization and reporting among the various diabetes populations.

Consulter en ligne

Suggestions

Du même auteur

Consensus Recommendations for the Use of Automated Insulin Delivery (AID) Technologies in Clinical Practice

Archive ouverte | Phillip, Moshe | CCSD

International audience. The significant and growing global prevalence of diabetes continues to challenge people with diabetes (PwD), healthcare providers and payers. While maintaining near-normal glucose levels has ...

International Consensus on Use of Continuous Glucose Monitoring

Archive ouverte | Danne, Thomas | CCSD

International audience. Measurement of glycated hemoglobin (HbA1c) has been the traditional method for assessing glycemic control. However, it does not reflect intra- and interday glycemic excursions that may lead t...

Continuous glucose monitoring and metrics for clinical trials: an international consensus statement

Archive ouverte | Battelino, Tadej | CCSD

International audience. Randomised controlled trials and other prospective clinical studies for novel medical interventions in people with diabetes have traditionally reported HbA1c as the measure of average blood g...

Chargement des enrichissements...